source
- New CDER appointment elevates longtime GLP-1 reviewerActing FDA CDER director Michael Davis has promoted a longtime FDA staffer as an acting deputy director at the drug center. Lisa Yanoff, an agency veteran with expertise in metabolic drug reviews,…Endpoints · 23d ago↗ source
- Bristol Myers details Krazati confirmatory study failure in colorectal cancerWhile Americans geared up for the July 4 holiday, Bristol Myers Squibb laid out how a confirmatory trial for its drug Krazati failed in colorectal cancer. Patients taking Krazati plus another drug,…Endpoints · 24d ago↗ source
- Roche aims to bolster breast cancer pipeline with early-stage Astex dealMonday’s deal between Otsuka’s subsidiary Astex Pharmaceuticals and Roche’s subsidiary Genentech is of interest not because it is big money — the upfront fee is just $25 million — but because of wh…